Optimization of hydantoins as potent antimycobacterial decaprenylphosphoryl-β-D-ribose oxidase (DprE1) inhibitors.
暂无分享,去创建一个
Robert H Bates | Fraser Cunningham | P. Van der Veken | E. Pitta | K. Augustyns | Lluís Ballell | S. Huss | Ángel Santos-Villarejo | M. Cacho | E. López-Román | D. Aguirre | L. Guijarro | Maciej K. Rogacki | Olga A. Balabon | E. Meiler | Ruth Casanueva | Mónica Cacho
[1] Christophe M. L. Vande Velde,et al. Identification and Profiling of Hydantoins-A Novel Class of Potent Antimycobacterial DprE1 Inhibitors. , 2018, Journal of medicinal chemistry.
[2] D. Schnappinger,et al. Discovery and Structure–Activity-Relationship Study of N-Alkyl-5-hydroxypyrimidinone Carboxamides as Novel Antitubercular Agents Targeting Decaprenylphosphoryl-β-d-ribose 2′-Oxidase , 2018, Journal of medicinal chemistry.
[3] P. Murumkar,et al. Overview of the Development of DprE1 Inhibitors for Combating the Menace of Tuberculosis. , 2018, Journal of medicinal chemistry.
[4] Alimuddin Zumla,et al. Accelerating the development of therapeutic strategies for drug-resistant tuberculosis , 2018, Nature Reviews Drug Discovery.
[5] G. Besra,et al. Determinants of the Inhibition of DprE1 and CYP2C9 by Antitubercular Thiophenes , 2017, Angewandte Chemie.
[6] T. Ioerger,et al. N-methylation of a bactericidal compound as a resistance mechanism in Mycobacterium tuberculosis , 2016, Proceedings of the National Academy of Sciences.
[7] Robert H Bates,et al. Searching for New Leads for Tuberculosis: Design, Synthesis, and Biological Evaluation of Novel 2-Quinolin-4-yloxyacetamides. , 2016, Journal of medicinal chemistry.
[8] S. Cole,et al. Discovery of benzothiazoles as antimycobacterial agents: Synthesis, structure-activity relationships and binding studies with Mycobacterium tuberculosis decaprenylphosphoryl-β-D-ribose 2'-oxidase. , 2015, Bioorganic & medicinal chemistry.
[9] G. Besra,et al. Whole Cell Target Engagement Identifies Novel Inhibitors of Mycobacterium tuberculosis Decaprenylphosphoryl-β-d-ribose Oxidase. , 2015, ACS infectious diseases.
[10] M. V. Rajasekharan,et al. Development of selective DprE1 inhibitors: Design, synthesis, crystal structure and antitubercular activity of benzothiazolylpyrimidine-5-carboxamides. , 2015, European journal of medicinal chemistry.
[11] S. Cole,et al. DprE1 Is a Vulnerable Tuberculosis Drug Target Due to Its Cell Wall Localization. , 2015, ACS chemical biology.
[12] Maria Paola Costi,et al. 2-Carboxyquinoxalines kill mycobacterium tuberculosis through noncovalent inhibition of DprE1. , 2015, ACS chemical biology.
[13] Christopher B. Cooper,et al. Lead optimization of 1,4-azaindoles as antimycobacterial agents. , 2014, Journal of medicinal chemistry.
[14] J. Mckinney,et al. 4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity. , 2014, Journal of medicinal chemistry.
[15] A. Narayan,et al. Discovery of pyrazolopyridones as a novel class of noncovalent DprE1 inhibitor with potent anti-mycobacterial activity. , 2014, Journal of medicinal chemistry.
[16] Vijay T. Ahuja,et al. Azaindoles: noncovalent DprE1 inhibitors from scaffold morphing efforts, kill Mycobacterium tuberculosis and are efficacious in vivo. , 2013, Journal of medicinal chemistry.
[17] Peter G. Schultz,et al. University of Birmingham Identification of a small molecule with activity against drug-resistant and persistent tuberculosis , 2013 .
[18] N. Loman,et al. Tetrahydropyrazolo[1,5-a]Pyrimidine-3-Carboxamide and N-Benzyl-6′,7′-Dihydrospiro[Piperidine-4,4′-Thieno[3,2-c]Pyran] Analogues with Bactericidal Efficacy against Mycobacterium tuberculosis Targeting MmpL3 , 2013, PloS one.
[19] A. Oliver,et al. Thiolates chemically induce redox activation of BTZ043 and related potent nitroaromatic anti-tuberculosis agents. , 2013, Journal of the American Chemical Society.
[20] Alfonso Mendoza,et al. Fueling Open-Source Drug Discovery: 177 Small-Molecule Leads against Tuberculosis , 2013, ChemMedChem.
[21] Steven J Novick,et al. Development of a high-throughput electrophysiological assay for the human ether-à-go-go related potassium channel hERG. , 2013, Journal of pharmacological and toxicological methods.
[22] R. Read,et al. Supplementary Materials for Structural Basis for Benzothiazinone-Mediated Killing of Mycobacterium tuberculosis , 2012 .
[23] G. Besra,et al. University of Birmingham Structural basis of inhibition of Mycobacterium tuberculosis DprE1 by benzothiazinone inhibitors , 2012 .
[24] S. Cole,et al. Benzothiazinones are suicide inhibitors of mycobacterial decaprenylphosphoryl-β-D-ribofuranose 2'-oxidase DprE1. , 2012, Journal of the American Chemical Society.
[25] J. C. Ruble,et al. Mild Pd-catalyzed N-arylation of methanesulfonamide and related nucleophiles: avoiding potentially genotoxic reagents and byproducts. , 2011, Organic letters.
[26] Stewart T. Cole,et al. Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis , 2009, Science.
[27] H. Bucherer,et al. Über die Bildung substituierter Hydantoine aus Aldehyden und Ketonen. Synthese von Hydantoinen , 1934 .